• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Metabolic fate of phenobarbital in man. N-Glucoside formation.

作者信息

Tang B K, Kalow W, Grey A A

出版信息

Drug Metab Dispos. 1979 Sep-Oct;7(5):315-8.

PMID:40773
Abstract

1-(beta-D-Glucopyranosyl)phenobarbital was identified as the major metabolite of phenobarbital in man. Proof of structure was based on the comparison of the UV, NMR, and mass spectrometry and TLC data for the acetylated metabolite with an authentic compound. The previous erroneous structure assignment of this metabolite as N-hydroxyphenobarbital was based on insufficient data. After oral administration of 14C-labeled phenobarbital to two healthy male subjects, most of the radioactivity (87 and 78% of the dose) was recovered in urine over a period of 16 days. The N-glucopyranoside, p-hydroxyphenobarbital, and unchanged phenobarbital accounted for 30 and 24%, 18 and 19%, and 33 and 25% of the dose, respectively.

摘要

相似文献

1
Metabolic fate of phenobarbital in man. N-Glucoside formation.
Drug Metab Dispos. 1979 Sep-Oct;7(5):315-8.
2
Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
Drug Metab Dispos. 1977 Jan-Feb;5(1):63-70.
3
Identification of phenobarbital N-glucuronides as urinary metabolites of phenobarbital in mice.
Drug Metab Dispos. 1995 May;23(5):548-52.
4
Determination of phenobarbital, p-hydroxyphenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometry.
Biomed Mass Spectrom. 1984 Sep;11(9):462-5. doi: 10.1002/bms.1200110905.
5
Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.P物质受体拮抗剂CP-122,721在人体内的代谢、药代动力学及排泄:采用高效液相色谱-串联质谱法和核磁共振光谱法对新型主要循环代谢物5-三氟甲氧基水杨酸进行结构表征
Drug Metab Dispos. 2007 Jun;35(6):884-97. doi: 10.1124/dmd.106.014266. Epub 2007 Mar 14.
6
Simultaneous determination of phenobarbital and p-hydroxyphenobarbital and their stable isotope labeled analogs by gas chromatography mass spectrometry.
Biomed Mass Spectrom. 1982 May;9(5):201-7. doi: 10.1002/bms.1200090505.
7
Disposition and metabolism of radiolabeled casopitant in humans.放射性标记的卡索匹坦在人体内的处置与代谢。
Drug Metab Dispos. 2009 Aug;37(8):1635-45. doi: 10.1124/dmd.109.026781. Epub 2009 May 6.
8
N-Hydroxylation of pentobarbital in man.人体内戊巴比妥的N-羟基化作用。
Drug Metab Dispos. 1977 Jan-Feb;5(1):71-4.
9
Metabolism of bepridil in laboratory animals and humans.苄普地尔在实验动物和人类中的代谢。
Drug Metab Dispos. 1988 Jan-Feb;16(1):69-77.
10
N-hydroxyamobarbital: the second major metabolite of amobarbital in man.N-羟基异戊巴比妥:人体内异戊巴比妥的第二种主要代谢产物。
Drug Metab Dispos. 1975 Nov-Dec;3(6):479-86.

引用本文的文献

1
A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients.吗啡的一种新代谢途径:癌症患者中吗啡葡糖苷的形成。
Br J Clin Pharmacol. 2003 Jun;55(6):570-8. doi: 10.1046/j.1365-2125.2003.01794.x.
2
Urinary excretion of phenobarbitone and its metabolites in chronically treated patients.
Eur J Clin Pharmacol. 1994;46(5):473-5. doi: 10.1007/BF00191914.
3
Inhibition of phenobarbitone N-glucosidation by valproate.丙戊酸盐对苯巴比妥N-葡萄糖苷化的抑制作用。
Br J Clin Pharmacol. 1994 Nov;38(5):411-6. doi: 10.1111/j.1365-2125.1994.tb04375.x.
4
Identification of the diastereomers of pentobarbital N-glucosides excreted in human urine.人尿中排泄的戊巴比妥 N-葡萄糖苷非对映体的鉴定。
Pharm Res. 1994 Nov;11(11):1535-9. doi: 10.1023/a:1018989116505.
5
The fate of phenobarbitone in children in hypothermia and at normal body temperature.
Can Anaesth Soc J. 1982 Jan;29(1):16-23. doi: 10.1007/BF03007942.
6
Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration.
Br J Clin Pharmacol. 1983 Apr;15(4):459-64. doi: 10.1111/j.1365-2125.1983.tb01530.x.
7
Ethnic differences in drug metabolism.药物代谢中的种族差异。
Clin Pharmacokinet. 1982 Sep-Oct;7(5):373-400. doi: 10.2165/00003088-198207050-00001.
8
Anticonvulsant drugs. An update.抗惊厥药物。最新进展。
Drugs. 1984 Apr;27(4):328-63. doi: 10.2165/00003495-198427040-00003.
9
N1-glucosides as urinary metabolites of sulphadimidine, sulphamerazine and sulphamethoxazole.N1-葡萄糖苷作为磺胺嘧啶、磺胺甲嘧啶和磺胺甲恶唑的尿液代谢产物。
Eur J Drug Metab Pharmacokinet. 1988 Jul-Sep;13(3):177-83. doi: 10.1007/BF03189937.
10
Stability of phenobarbital N-glucosides: identification of hydrolysis products and kinetics of decomposition.苯巴比妥N-葡萄糖苷的稳定性:水解产物的鉴定及分解动力学
Pharm Res. 1989 Jun;6(6):458-65. doi: 10.1023/a:1015908221339.